If you cover healthcare names, you know how rarely one dataset tells the whole story. Research Signal Healthcare brings pharmacy claims, medical claims and hospital purchase data into one analyst-built read, timed ahead of the print.
One dataset rarely tells the whole story
For devices, hospital purchasing data tracks brand-level demand, and claims data adds real-world utilization trends, the growth drivers behind it. For drugs, the right view depends on the channel: pharmacy claims for specialty and retail products, medical claims for physician-administered and infusion products, and both for drugs that move through each. Each source answers part of the question. Putting the pieces together before earnings takes time most analysts don’t have.
Research Signal Healthcare does that work for you. Each report is built by Consumer Edge’s healthcare team and turned into a finished read on the trends, competitive dynamics and drivers shaping a company’s quarter. No other research product currently spans all three data types.
Three lenses on every name
Each report stands on its own as a finished read, and it is even more useful when a company needs more than one perspective. Device purchasing sits beside procedure volume. A drug’s pharmacy trend sits beside its physician-administered volume.
When two independent signals point the same way, you get a read you can trust. When they diverge, you see it early and know where to dig.
Two reads per quarter, timed to your decisions
Research is most valuable when it arrives while the decision is still open.
A forecast you can check for yourself
An estimate is only as useful as the confidence you can place in it. Each quarter-end earnings report puts a Consumer Edge revenue forecast beside Visible Alpha consensus, along with a backtest of Consumer Edge estimates against reported results. The track record sits at the top of the report, so you decide how much weight to give it before you size a position.
What’s in every report
- ✓Key takeaways with hard numbers
- ✓Consumer Edge revenue forecast beside Visible Alpha consensus
- ✓Backtest of Consumer Edge estimates vs. reported results
- ✓Volume trends and the drivers behind them
- ✓Competitive share, site of care, payer mix, indication mix and persistence
- ✓Management commentary checked against the data
- ✓Risks and considerations specific to the name
- ✓PDF plus a companion Excel file with every underlying number
Portfolio managers get the finished read. Data teams get everything they need to go deeper. Reports are built at the level that gives the clearest answer: a single product, a franchise, a company, or a competitive market across several companies.
Frequently asked questions
Research Signal Healthcare is analyst-built healthcare equity research from Consumer Edge. Each report turns pharmacy claims, medical claims and hospital purchase data into a finished read on the trends, competitive dynamics and drivers shaping a company’s quarter, timed ahead of earnings.
Reports draw on Consumer Edge’s proprietary pharmacy claims, medical claims and hospital purchase data, alongside Visible Alpha consensus. Where a company benefits from more than one lens, the report combines datasets so two independent signals can be checked against each other.
Each covered name gets two reads per quarter: an intra-quarter trends report on whether the name is accelerating or decelerating, and a quarter-end earnings report ahead of the print with the Consumer Edge revenue forecast, the backtest behind it, and management commentary checked against the data.
Coverage launches with 10 reports across pharma, biotech and medtech, built at the product, franchise, ticker or market level. Clients can request names through their account manager.